METHODS AND COMPOSITIONS FOR TREATING CANCER
    7.
    发明公开
    METHODS AND COMPOSITIONS FOR TREATING CANCER 审中-公开
    治疗癌症的方法和组合物

    公开(公告)号:EP3200815A1

    公开(公告)日:2017-08-09

    申请号:EP15847792.7

    申请日:2015-09-30

    IPC分类号: A61K38/24

    摘要: A nucleic acid sequence is provided that encodes a chimeric protein comprising a ligand that comprises a naturally occurring or modified follicle stimulating hormone sequence, e.g., an FSHp sequence, or fragment thereof, which ligand binds to human follicle stimulating hormone (FSH) receptor, linked to either (a) a nucleic acid sequence that encodes an extracellular hinge domain, a transmembrane domain, a co-stimulatory signaling region, and a signaling endodomain; or (b) a nucleic acid sequence that encodes a ligand that binds to NKG2D. The vector containing the nucleic acid sequence, the chimeric proteins so encoded, and modified T cells expressing the chimeric protein, as well as method of using these compositions for the treatment of FSHR-expressing cancers or tumor cells are also provided.

    摘要翻译: 提供编码嵌合蛋白的核酸序列,所述嵌合蛋白包含配体,所述配体包含天然存在的或修饰的促卵泡激素序列,例如FSHp序列或其片段,所述配体结合人卵泡刺激素(FSH)受体, (a)编码细胞外铰链结构域,跨膜结构域,共刺激信号传导区域和信号传导内源结构域的核酸序列; 或(b)编码结合NKG2D的配体的核酸序列。 还提供了包含核酸序列的载体,如此编码的嵌合蛋白以及表达嵌合蛋白的修饰的T细胞,以及使用这些组合物治疗表达FSHR的癌症或肿瘤细胞的方法。

    METHOD FOR IDENTIFYING A COMPOUND THAT MODULATES TELOMERASE ACTIVITY
    9.
    发明公开
    METHOD FOR IDENTIFYING A COMPOUND THAT MODULATES TELOMERASE ACTIVITY 审中-公开
    一种用于识别端粒酶活性来调节CONNECTION

    公开(公告)号:EP2205759A1

    公开(公告)日:2010-07-14

    申请号:EP08840994.1

    申请日:2008-10-21

    IPC分类号: C12Q1/48

    CPC分类号: C12Q1/48 G01N2333/91245

    摘要: The present invention relates to a method for identifying compounds that modulate the activity of telomerase. Compounds of the invention are identified by designing or screening for a compound which binds to at least one amino acid residue of the TRBD, 'thumb,' 'finger,' and/or 'palm' domain of telomerase and testing the compound for its ability to modulate the activity of telomerase.